PlainRecalls
FDA Drug Moderate Class II Terminated

Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.

Reported: October 5, 2022 Initiated: September 16, 2022 #D-1543-2022

Product Description

Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.

Reason for Recall

CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

Details

Units Affected
132,999 cartons
Distribution
Nationwide and Puerto Rico
Location
East Hanover, NJ

Frequently Asked Questions

What product was recalled?
Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.. Recalled by Novartis Pharmaceuticals Corporation. Units affected: 132,999 cartons.
Why was this product recalled?
CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 5, 2022. Severity: Moderate. Recall number: D-1543-2022.